Most pharmaceutical or Biotechs do not have the facilities, funds or expertise to to do their own marketing or manufacturing of the their products and they either farm them out or establish joint venture and other relationship. They generally receive a very small portion of the profits as they have farmed out most of the marketing and manufacturing etc. AMPH is a vertically integrated company and does everything in house. When you farm out your products you do not have ultimate control over the it and when they get in trouble with the FDA you are handicapped and unable to meet your schedules and marketing commitments. Mankind have to contract with AMPH to manufacture its products. Momenta have to do likewise and so are many of the biotechs company due to a lack of resources and facilities that is already approved by the FDA for such purpose.
johnboy2680 • Mar 5, 2015 9:48 PM Flag
just my clients get the right information when I posts
I write in code so only my clients kn ow if my message is right or wrong
goog message boards
Keep trying Rf-Rat ......you are the one who was proven to have lost money here.....the old timers here know what I own and know I am most certainly not in the red. I only have to be right once.....and that will be when Eli 200 launches. Next LOL
That would explain the apparent lack of panic to cover..
Macks, pipline mm121is a huge deal and I don't think he is going for an average deal I think it will be very excellent for mack that is why I think it has taken longer than we would like. If baxter has first right of refusal on the rest of their pipeline who is to say baxter won't make the right offer to bob on the whole ball of wax. I know what their original deal was but bob and the board can change their mind a lot of key insiders bought thousands of shares not counting options in the open mkt. If someone like baxter offered 35per share. Ithink they would say yes.
Sentiment: Strong Buy
As my wife is a Director of Marketing for a company even smaller than MVIS, I actually know (second hand) a bit about such subjects as Facebook ads, Google ads, etc. They're actually quite cost effective and flexible. Pretty easy to set budget limits and targeting parameters.
So while I would not be generally in favor of MVIS "going wide" with an advertising campaign at this stage of their development, this strikes me as a cost effective use of what must be (and should be at this point) a limited advertising budget.
Sentiment: Strong Buy
Fatzman, you've been correct as have I been correct. The only good news now would be for the departure of D.J. and his board of mis-directors.
Sentiment: Strong Sell
What can be the impact of June 2 voting to increase common stock?
In either way, it could be good IMO! If Yes, then concerns over SRPT's cash burn should be over and future trails will get a boost. If No, there will be s short squeeze!
A week after Hanergy Thin Film Power lost half its market value, investors are still stuck. On halt since last Wednesday, the stock exemplifies the problem of incredibly long suspensions for controversial shares in Hong Kong.
Both her and Matt Herpes have been so blatantly subjective (if not libelous) that one can only surmise Forbes is being paid off by GSK or they are themselves shorting amrn. Forbes has gotten worse than Seeking Alpha.